Skip to content
Boston Health Longevity

Stem Cell Therapy for Psoriasis in Thailand

An immunomodulatory approach to managing chronic skin inflammation

Apply for Assessment No-obligation consultation
Clinician-Led
International Patients
Competitive Pricing
Testimonials →

Understanding Psoriasis

Psoriasis is a chronic autoimmune condition characterised by accelerated skin cell turnover, leading to thick, scaly plaques that cause significant physical discomfort and psychological distress. The underlying pathophysiology involves dysregulated T-cell activity and elevated pro-inflammatory cytokines including TNF-alpha, IL-17, and IL-23 that drive persistent skin inflammation. When conventional treatments such as topical corticosteroids, phototherapy, and systemic immunosuppressants fail to provide adequate control, patients seek alternative approaches. Mesenchymal stem cells have demonstrated immunomodulatory and anti-inflammatory properties in clinical research, with the potential to help regulate the overactive immune response driving psoriatic inflammation. Treatment is delivered at Boston Health Longevity in Chiang Mai with careful patient assessment and personalised protocols.

Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.

What Causes Psoriasis?

Genetic predisposition is a major factor, with over 80 gene loci linked to psoriasis susceptibility. Having a first-degree relative with psoriasis significantly increases risk, though environmental triggers are needed to activate the disease.

Immune system dysfunction drives psoriasis at a cellular level. Overactive T-cells, particularly Th17 cells, produce inflammatory cytokines (IL-17, IL-23, TNF-alpha) that accelerate skin cell production from the normal 28-day cycle to just 3-4 days.

Environmental triggers including psychological stress, infections (particularly streptococcal throat infections), skin injury (the Koebner phenomenon), certain medications (lithium, beta-blockers, antimalarials), and excessive alcohol consumption can initiate or worsen flares.

Disruption of the skin barrier and microbiome contributes to disease perpetuation. Altered microbial communities on psoriatic skin may sustain inflammatory signalling and impair normal immune tolerance.

Metabolic factors including obesity and insulin resistance are associated with more severe psoriasis. Adipose tissue produces pro-inflammatory cytokines that may amplify the systemic inflammatory burden driving skin disease.

Common Signs and Symptoms

Raised, red or salmon-coloured plaques covered with silvery-white scales, most commonly appearing on the elbows, knees, scalp, and lower back. Plaques can vary from small patches to extensive body coverage.

Persistent itching, burning, or stinging at plaque sites that can range from mildly irritating to severely disabling, often disrupting concentration and sleep quality.

Dry, cracked skin that may bleed, particularly on the hands and feet where skin is subject to daily mechanical stress.

Nail changes including pitting, discolouration, thickening, crumbling, or separation from the nail bed (onycholysis), affecting up to 50% of patients with skin psoriasis.

Joint pain, stiffness, and swelling (psoriatic arthritis) develops in approximately 30% of psoriasis patients, causing progressive joint damage if untreated.

Scalp involvement causing thick, adherent plaques that extend beyond the hairline, often resistant to topical treatments and a source of significant social embarrassment.

Inverse psoriasis in skin folds (groin, armpits, under breasts) presenting as smooth, red, raw-looking patches that are particularly uncomfortable and difficult to manage.

Living With Psoriasis

Living with psoriasis extends far beyond the visible plaques on your skin. You may dread social situations, carefully choosing clothing to conceal affected areas, avoiding swimming pools, and declining invitations where your skin might be seen. The relentless itch can rob you of sleep and concentration, while the flaking and scaling feel impossible to manage discreetly. Many patients describe the humiliation of people recoiling or asking if their condition is contagious. The emotional burden is profound: studies show rates of depression and anxiety among psoriasis patients are significantly higher than the general population. Perhaps most frustrating is the unpredictable cycle of flares and remission, where periods of relative calm are shattered without warning, leaving you feeling that your body is beyond your control.

Conventional Treatment Options

Conventional psoriasis management follows a stepwise approach starting with topical corticosteroids, vitamin D analogues, and coal tar preparations for mild disease. Phototherapy (UVB or PUVA) is used for moderate disease, while systemic treatments including methotrexate, ciclosporin, and acitretin are reserved for more severe cases. Biologic agents targeting specific cytokines (TNF-alpha, IL-17, IL-23) have transformed outcomes for many patients but require ongoing injections or infusions, carry risks of infection and immune suppression, and can lose effectiveness over time. Many patients cycle through multiple treatments, experiencing partial responses, side effects, or diminishing returns. The chronic nature of the disease means lifelong treatment is expected, and the cumulative burden of medications, appointments, and side effect monitoring drives many patients to seek alternative approaches.

If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.

Is It Right For You?

Good Candidates

Patients with moderate to severe plaque psoriasis who have not achieved adequate disease control with conventional therapies including topical treatments, phototherapy, or systemic medications may be candidates. Those who have experienced adverse effects from long-term immunosuppressive therapy or biologic agents may also benefit from assessment. A thorough dermatological evaluation, review of treatment history, and assessment of disease severity using standardised scoring systems are required to confirm suitability.

Contraindications

Active severe psoriatic flare with erythrodermic or pustular presentation requiring immediate intervention
Active systemic or skin infection in treatment areas
Certain active malignancies or history of skin cancer in affected areas
Pregnancy or planned pregnancy within six months
Severely compromised immune function from concurrent immunosuppressive therapy
2025 Outcome Data

Clinical outcomes for psoriasis

Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.

64%

Symptom Reduction

Average improvement in disease activity scores across autoimmune conditions treated

52%

Medication Reduction

Patients able to reduce immunosuppressive medication with physician guidance

3-6 mo

Response Timeline

Typical period for immune modulation effects to become clinically measurable

78%

Flare Reduction

Patients reporting fewer or less severe disease flares in 12-month follow-up

Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.

How Stem Cell Therapy May Help

Immunomodulatory properties may help regulate the overactive T-cell response driving psoriatic inflammation
Anti-inflammatory effects targeting elevated pro-inflammatory cytokines such as TNF-alpha and IL-17
May support skin tissue repair and normalisation of skin cell turnover rates
Potential to reduce the frequency and severity of psoriatic flares
Complementary approach that may work alongside existing dermatological management
Personalised protocol considering your disease severity, affected areas, and treatment history
Why Thailand

Why Patients Choose Thailand for Psoriasis Treatment

1

Umbilical cord-derived MSC therapy for psoriasis is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced immunomodulatory therapies.

2

Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.

3

Transparent pricing with no hidden fees. Systemic autoimmune and inflammatory condition treatments range from $20,000 to $40,000 USD, with a clear breakdown provided during your no-obligation consultation.

4

Chiang Mai offers a warm, relaxed recovery environment that many patients find beneficial for skin conditions. Reduced stress, sunshine (in moderation), and distance from daily pressures may support the healing process.

5

Structured follow-up at 1, 3, 6, and 12 months with photographic documentation and biomarker tracking ensures your progress is monitored objectively long after you return home.

Treatment Comparison

Alternatives to immunosuppressants for psoriasis

Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.

Factor Stem Cell Therapy Conventional / Surgery
Typical Cost (Thailand) $20,000 - $40,000 N/A (no surgical equivalent)
Recovery Time 1-2 days minimal downtime Ongoing (continuous medication)
Invasiveness Minimally invasive infusion Ongoing systemic immunosuppressants / biologics
Hospital Stay Varies by protocol Outpatient (ongoing prescriptions)
Risk Level Low (cell-based, minimal side effects) Variable (immunosuppression, liver toxicity, infection risk)
Return to Normal Activity 1-3 days Continuous treatment with potential side effects

Treatment at Boston Health Longevity

$20,000 - $40,000

USD equivalent, personalised to your case

vs Home Country

N/A (no surgical equivalent)

Internationally competitive pricing, same clinical standard

Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.

Wondering if you're a candidate?

Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.

Request Assessment

Trusted by international patients from 11+ countries worldwide

Your Journey

What to expect

1

Detailed remote consultation including dermatological history and photography review

2

Arrive in Chiang Mai, accommodation and transfer guidance provided

3

Day 1: Comprehensive dermatological assessment, blood work, and disease severity scoring

4

Day 2: Stem cell preparation and administration via intravenous infusion

5

Day 3-5: Monitoring, skin assessment, and discharge with care plan

6

Structured remote follow-up at 1, 3, 6, and 12 months with photographic documentation

Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →

Frequently Asked Questions

Can stem cell therapy cure psoriasis?
No. Psoriasis is a chronic condition and stem cell therapy is not a cure. It is an emerging immunomodulatory approach that may help reduce the frequency and severity of flares by modulating the immune response. We provide transparent expectations during your consultation.
Will I need to stop my current psoriasis medications?
This is assessed individually based on your current treatment regimen. Some medications may need temporary adjustment around the treatment period. All changes are discussed with our team and coordinated with your dermatologist at home to ensure continuity of care.
How long before I may see improvement in my skin?
Individual responses vary significantly. Some patients report gradual improvements in skin condition over 2-4 months following treatment. The immunomodulatory effects of stem cell therapy develop progressively, and ongoing monitoring helps track your individual response.
Is this suitable for psoriatic arthritis as well?
Patients with psoriatic arthritis may also be assessed for treatment, as the immunomodulatory properties of mesenchymal stem cells may address both the skin and joint components of the disease. Each case is evaluated individually based on disease presentation and severity.
Next Steps

Ready to explore psoriasis treatment?

Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.

Most patients receive their initial assessment within 24 hours.

1

Submit Your Case

Share your medical history and imaging for review.

2

Clinical Assessment

Our team reviews your case and provides an honest recommendation.

3

Treatment Plan

Receive a personalised plan with transparent pricing.

Related Conditions

Other conditions we treat

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Take the first step

Request a no-obligation assessment for psoriasis treatment at Boston Health Longevity in Chiang Mai.

52

Conditions Treated

11

Countries Served

GMP

Certified Supply

Request Assessment

Every case personally reviewed by our clinical team within 24 hours

Apply for Consultation